临床试验
维生素
机制(生物学)
抗氧化剂
医学
维生素C
疾病
重症监护医学
生理学
内科学
生物
生物化学
哲学
认识论
作者
Richard Bedlack,Paul E. Barkhaus,Gregory Carter,Jesse Crayle,Christopher McDermott,Gary L. Pattee,Meraida Polak,Kristiana Salmon,Paul Wicks
标识
DOI:10.1080/21678421.2021.1946088
摘要
Vitamin C is one of the most common supplements taken by people with ALS. As an antioxidant, it has a plausible mechanism for slowing disease progression and there are some flawed pre-clinical studies and case reports suggesting benefit. However, a small human trial showed no benefit. Given this negative trial, we do not currently advise vitamin C as an ALS treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI